2021 annual financial data
Ironwood Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was 56.13%.
Operating income was 232,259,000 USD and net income was 528,448,000 USD.
Operating cash flow was 261,895,000 USD.
Get free Ironwood Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 413,753,000 USD
- Operating income
- 232,259,000 USD
- Net income
- 528,448,000 USD
- Operating cash flow
- 261,895,000 USD